Exosomes: the next frontier in vaccine development and delivery
- PMID: 39007145
- PMCID: PMC11239336
- DOI: 10.3389/fimmu.2024.1435426
Exosomes: the next frontier in vaccine development and delivery
Abstract
Exosomes are small disk-shaped extracellular vesicles (EVs) that are naturally released into the environment by different types of cells. Exosomes range from 30-150 nm in size and contain complex RNA and proteins. They are widely found in body fluids such as blood, saliva, urine and breast milk and participate in cell communication by functioning as cell messengers. Almost all cell types can transmit information and exchange substances through the production and release of exosomes to regulate proliferation, differentiation, apoptosis, the immune response, inflammation, and other biological functions. Because exosomes exist widely in various body fluids, they are easy to obtain and detect and have the potential for use in disease diagnosis and prognosis detection. Exosomes can be genetically fused with targeted proteins, enhancing their biocompatibility and immunogenicity. Therefore, exosomes are the preferred vector tools for vaccines. In this review, we describe the characteristics of exosomes and discuss their unique and ambiguous functions in the immune microenvironment after infection. In this regard, we explored the ability of exosomes to carry immunogenic virus antigens and to establish adaptive immune responses. Exosomes can provide an interesting platform for antigen presentation and since vaccines are a powerful method for the prevention of infectious diseases, we further review the advantages and disadvantages of the use of exosomes in vaccine preparation. Overall, exosomes are emerging as a promising avenue for vaccine development.
Keywords: antigen presentation; exosomes; extracellular vesicles; immune responses; vaccine.
Copyright © 2024 Tan, Li, Fu and Lei.
Conflict of interest statement
The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
Similar articles
-
Exosome-Mediated Antigen Delivery: Unveiling Novel Strategies in Viral Infection Control and Vaccine Design.Vaccines (Basel). 2024 Mar 7;12(3):280. doi: 10.3390/vaccines12030280. Vaccines (Basel). 2024. PMID: 38543914 Free PMC article. Review.
-
Extracellular vesicles - A promising avenue for the detection and treatment of infectious diseases?Eur J Pharm Biopharm. 2017 Sep;118:56-61. doi: 10.1016/j.ejpb.2017.04.005. Epub 2017 Apr 7. Eur J Pharm Biopharm. 2017. PMID: 28396279 Review.
-
Exosomes multifunctional roles in HIV-1: insight into the immune regulation, vaccine development and current progress in delivery system.Front Immunol. 2023 Oct 27;14:1249133. doi: 10.3389/fimmu.2023.1249133. eCollection 2023. Front Immunol. 2023. PMID: 37965312 Free PMC article. Review.
-
Potential Application of Exosomes in Vaccine Development and Delivery.Pharm Res. 2022 Nov;39(11):2635-2671. doi: 10.1007/s11095-021-03143-4. Epub 2022 Jan 13. Pharm Res. 2022. PMID: 35028802 Free PMC article. Review.
-
Exosomes: Nanoparticulate tools for RNA interference and drug delivery.J Cell Physiol. 2017 Jul;232(7):1660-1668. doi: 10.1002/jcp.25766. Epub 2017 Jan 31. J Cell Physiol. 2017. PMID: 28063231 Free PMC article. Review.
Cited by
-
Beyond the Pandemic Era: Recent Advances and Efficacy of SARS-CoV-2 Vaccines Against Emerging Variants of Concern.Vaccines (Basel). 2025 Apr 17;13(4):424. doi: 10.3390/vaccines13040424. Vaccines (Basel). 2025. PMID: 40333293 Free PMC article. Review.
-
Strategic Advances in Targeted Delivery Carriers for Therapeutic Cancer Vaccines.Int J Mol Sci. 2025 Jul 17;26(14):6879. doi: 10.3390/ijms26146879. Int J Mol Sci. 2025. PMID: 40725126 Free PMC article. Review.
-
Nucleic acid vaccines: innovations, efficacy, and applications in at-risk populations.Front Immunol. 2025 May 14;16:1584876. doi: 10.3389/fimmu.2025.1584876. eCollection 2025. Front Immunol. 2025. PMID: 40438110 Free PMC article. Review.
-
Advances in the Functionalization of Vaccine Delivery Systems: Innovative Strategies and Translational Perspectives.Pharmaceutics. 2025 May 12;17(5):640. doi: 10.3390/pharmaceutics17050640. Pharmaceutics. 2025. PMID: 40430931 Free PMC article. Review.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources